ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 88 filers reported holding ADURO BIOTECH INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,000 | 0.0% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $13,000 | -13.3% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | +114.3% | 5,545 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | +16.7% | 5,545 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 5,545 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -59.1% | 5,545 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $22,000 | +46.7% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $15,000 | -63.4% | 5,545 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $41,000 | +5.1% | 5,545 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $39,000 | +18.2% | 5,545 | +55.1% | 0.00% | 0.0% |
| Q1 2018 | $33,000 | +22.2% | 3,574 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $27,000 | -37.2% | 3,574 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $43,000 | +4.9% | 3,574 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $41,000 | +36.7% | 3,574 | +29.4% | 0.00% | +100.0% |
| Q1 2017 | $30,000 | – | 2,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 640,595 | $4,708,000 | 1.20% |
| BVF INC/IL | 287,776 | $2,115,000 | 0.19% |
| ORACLE INVESTMENT MANAGEMENT INC | 111,542 | $820,000 | 0.18% |
| Sofinnova Investments, Inc. | 189,579 | $1,393,000 | 0.12% |
| CENTAURUS FINANCIAL, INC. | 85 | $624,000 | 0.11% |
| Artal Group S.A. | 550,000 | $4,043,000 | 0.10% |
| Vident Investment Advisory, LLC | 305,311 | $2,244,000 | 0.09% |
| Virtus ETF Advisers LLC | 61,463 | $452,000 | 0.05% |
| Foundry Partners, LLC | 106,907 | $786,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 239,301 | $1,759,000 | 0.02% |